These are birth defects or health problems that can happen to a baby if the mother takes certain medications or drugs during pregnancy. It's important to talk to your doctor about any medications you are taking before becoming pregnant.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Drug-induced abnormalities are birth defects or other developmental problems in a baby that are caused by a medicine or another drug taken during pregnancy. A substance that can cause this kind of harm is called a teratogen. The effect falls on the developing baby rather than on the person taking the medicine, which is what sets this apart from an ordinary side effect. The harm can be structural, meaning a body part forms differently, as with spina bifida (an opening in the spine), a heart defect or a cleft lip. It can also be functional, affecting how the brain or another organ works without changing how it looks, for example lower thinking and learning abilities later in childhood. Some exposures instead affect the baby's growth or lead to miscarriage or early birth. How much a drug-induced abnormality affects a child's life depends on which part of the body is involved and how severe the problem is.
Only a small number of medicines are well established as causes of birth defects. Examples include valproate, a seizure and mood-stabilizing medicine that raises the chance of spina bifida and other major defects and can lower a child's later scores on intelligence (IQ) tests; isotretinoin, an acne medicine for which even a short exposure carries a very high risk of serious defects; ACE (angiotensin-converting enzyme) inhibitors and related blood pressure medicines, which can injure the developing baby; and methotrexate, used for some forms of arthritis and cancer. Other seizure medicines, including carbamazepine and topiramate, also carry known risks. Alcohol and some street drugs can cause lasting harm too, as in fetal alcohol spectrum disorders. Timing matters as much as the substance. Most structural birth defects arise in the first trimester (the first three months), when the heart, limbs, lips, palate and other organs are forming. A drug generally has to be present while a particular body part is forming to change its shape, so a medicine that can cause cleft lip early in pregnancy is unlikely to do so at 20 weeks. Later exposures can still affect growth or how organs work. Dose, how often the drug is taken and how it enters the body also play a part. For many medicines, the risk is simply not well known, because pregnant people are rarely included in studies and most teratogens are identified only after a medicine is in wide use. An unknown risk is not the same as a proven risk, which is why advice is specific to each medicine and each stage of pregnancy.
Some abnormalities are found during pregnancy through routine prenatal testing, which can show how the baby is developing. Others are obvious at birth, are picked up by newborn screening or only become apparent later, when a child's development or learning is assessed. Isotretinoin is a notable example where no prenatal test can reliably show whether an exposed baby has been affected. Linking a defect to a medicine is a matter of careful judgment rather than a single test. Clinicians compare which medicines were taken, when in pregnancy and at what dose with the pattern of differences known to follow that drug, and consider genetic and other causes. This matters because about 3 out of 100 babies are born with a birth defect whatever the exposure, so a defect that follows a medicine is not automatically caused by it. Genetics specialists and teratology information services such as MotherToBaby can help interpret a specific exposure.
There is no treatment that reverses an abnormality once it has formed, so care is aimed at the specific problem the child has. Depending on the defect, that may include surgery (for example to repair a heart defect, cleft lip or spina bifida), medicines, assistive devices, physical therapy and speech therapy. Children often see several specialists, with a primary care clinician coordinating their care. Much of the work happens before or early in pregnancy. Someone taking a medicine with known risks can review it with their prescriber before trying to conceive, and sometimes switch to an alternative, use the lowest effective dose or add folic acid. Medicines with the highest risks, such as isotretinoin, are prescribed only with pregnancy tests and reliable contraception. The trade-off is real: an untreated condition such as epilepsy, severe depression or high blood pressure can itself harm both parent and baby, so stopping a needed medicine is not automatically the safer choice.
Outcomes vary widely. Many exposures to a medicine during pregnancy do not lead to any abnormality, and when one does occur it may be minor and need no treatment, or it may be a serious condition that requires surgery and long-term support. Effects on learning and behavior may not be clear until a child is older, so ongoing developmental checks are part of follow-up. Parents who learn of an exposure often feel worried or guilty. Many pregnancies are exposed to medicines before anyone knows of the pregnancy, and an individual assessment usually gives a clearer and more realistic picture than general warnings. Pregnancy exposure registries, which track outcomes after specific medicines, are one way families can help improve what is known for others.
If you take any regular medicine and are planning a pregnancy, arrange a visit with your prescriber beforehand to review whether each medicine is right to continue. Do not stop a prescribed medicine on your own when you find out you are pregnant, since stopping some medicines abruptly can be dangerous, but contact your prescriber right away. If you become pregnant while taking isotretinoin, stop it immediately and contact your prescriber, who should refer you to a specialist for evaluation and counseling. If your child was exposed to a medicine during pregnancy and you notice delays in development, learning or behavior, raise it with the child's clinician so it can be assessed.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Drug-Induced Abnormalities is like, what's helped you, or ask the community a question.